Lipid emulsions in parenteral nutrition: Current applications and future developments

Expert Opinion on Drug Delivery

Volumn 10, Issue 11, 2013, Pages 1533-1549

  Ren, Tianyang ^a   Cong, Lin ^a   Wang, Yueqi ^a   Tang, Yilin ^b   Tian, Bin ^a   Lin, Xia ^a   Zhang, Yu ^a   Tang, Xing ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Fatty acids; Lipid emulsions; Lipid sources; Parenteral nutrition

Indexed keywords

BORAGE OIL; CARNITINE; CORN OIL; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; ESSENTIAL FATTY ACID; FAT; FISH OIL; GAMMA LINOLENIC ACID; ICOSANOID; ICOSAPENTAENOIC ACID; INSULIN; LINOLEIC ACID; LIPID EMULSION; LIPID PEROXIDE; LONG CHAIN FATTY ACID; LONG CHAIN TRIACYLGLYCEROL; MEDIUM CHAIN FATTY ACID; MEDIUM CHAIN TRIACYLGLYCEROL; MONOUNSATURATED FATTY ACID; OLEIC ACID; OLIVE OIL; OXYGEN RADICAL; POLYUNSATURATED FATTY ACID; PRIMROSE OIL; SAFFLOWER OIL; SOYBEAN OIL; UNINDEXED DRUG; VEGETABLE OIL; VITAMIN;

BLACK CURRANT; CARBON SOURCE; CELL MEMBRANE; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; CRITICALLY ILL PATIENT; ENERGY RESOURCE; HEPATOBILIARY DISEASE; HIPPOPHAE RHAMNOIDES; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IN VITRO STUDY; INFLAMMATION; LIPID METABOLISM; LIPID PEROXIDATION; METABOLIC DISORDER; METABOLISM; NEUTROPHIL CHEMOTAXIS; NONHUMAN; NUTRITIONAL SUPPORT; OXIDATION; OXIDATIVE STRESS; PARENTERAL NUTRITION; REVIEW; THERAPY EFFECT;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; EMULSIONS; HUMANS; LIPIDS; PARENTERAL NUTRITION; PARENTERAL NUTRITION SOLUTIONS;

EID: 84886602919     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2013.824874     Document Type: Review

References (155)

1. Waitzberg DL, Torrinhas RS, Jacintho TM. New parenteral lipid emulsions for clinical use. J Parenter Enteral Nutr 2006;30(4):351-67
2. Wanten GJ, Calder PC. Immune modulation by parenteral lipid emulsions. Am J Clin Nutr 2007;85(5):1171-84
3. Calder PC, Jensen GL, Koletzko BV, et al. Lipid emulsions in parenteral nutrition of intensive care patients: current thinking and future directions. Intensive Care Med 2010;36(5):735-49
4. Nordenstrom J, Jarstrand C, Wiernik A. Decreased chemotactic and random migration of leukocytes during Intralipid infusion. Am J Clin Nutr 1979;32(12):2416-22
5. Jarstrand C, Berghem L, Lahnborg G. Human granulocyte and reticuloendothelial system function during intra lipid infusion. J Parenter Enteral Nutr 1978;2(5):663-70
6. Roche LD. Oxidative stress: the dark side of soybean-oil-based emulsions used in parenteral nutrition. Oxid Antioxid Med Sci 2012;1(1):11-14
7. Wiernik A, Jarstrand C, Julander I. The effect of intralipid on mononuclear and polymorphonuclear phagocytes. Am J Clin Nutr 1983;37(2):256-61
8. Sedman P, Ramsden C, Brennan T, Guillou P. Pharmacological concentrations of lipid emulsions inhibit interleukin-2-dependent lymphocyte responses in vitro. J Parenter Enteral Nutr 1990;14(1):12-17
9. Sailer D, Muller M. Medium chain triglycerides in parenteral nutrition. J Parenter Enteral Nutr 1981;5(2):115-19
10. Sato N, Deckelbaum RJ, Neeser G, et al. Hydrolysis of mixed lipid emulsions containing medium-chain and long-chain triacylglycerol with lipoprotein lipase in plasma-like medium. J Parenter Enteral Nutr 1994;18(2):112-18
11. Johnson RC, Young SK, Cotter R, et al. Medium-chain-triglyceride lipid emulsion: metabolism and tissue distribution. Am J Clin Nutr 1990;52(3):502-8
12. Geliebter A, Torbay N, Bracco EF, et al. Overfeeding with medium-chain triglyceride diet results in diminished deposition of fat. Am J Clin Nutr 1983;37(1):1-4
13. Ulrich H, Pastores SM, Katz DP, Kvetan V. Parenteral use of medium-chain triglycerides: a reappraisal. Nutrition 1996;12(4):231-8
14. Ball M. Parenteral nutrition in the critically ill: use of a medium chain triglyceride emulsion. Intensive Care Med 1993;19(2):89-95
15. Bach A, Guiraud M, Gibault J, et al. Medium chain triglycerides in septic patients on total parenteral nutrition. Clin Nutr 1988;7(3):157-63
16. Jiang ZM, Zhang SY, Wang XR, et al. A comparison of medium-chain and long-chain triglycerides in surgical patients. Ann Surg 1993;217(2):175-84
17. Shizgal HM, Posner B. Insulin and the efficacy of total parenteral nutrition. Am J Clin Nutr 1989;50(6):1355-63
18. Halliwell B, Chirico S. Lipid peroxidation: its mechanism, measurement, and significance. Am J Clin Nutr 1993;57(5):715S-24S
19. Dargel R. Lipid peroxidation-a common pathogenetic mechanism? Exp Toxicol Pathol 1992;44(4):169-81
20. Esterbauer H. Cytotoxicity and genotoxicity of lipid-oxidation products. Am J Clin Nutr 1993;57(5):779S-85S
21. Eritsland J. Safety considerations of polyunsaturated fatty acids. Am J Clin Nutr 2000;71(1):197S-201S
22. Pontes-Arruda A. Biological benefits of an oleic acid-rich lipid emulsion for parenteral nutrition. Clin Nutr Suppl 2009;4(1):19-23
23. Kalogeropoulos N, Panagiotakos DB, Pitsavos C, et al. Unsaturated fatty acids are inversely associated and n-6/n-3 ratios are positively related to inflammation and coagulation markers in plasma of apparently healthy adults. Clin Chim Acta 2010;411(7):584-91
24. Baer DJ, Judd JT, Clevidence BA, Tracy RP. Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. Am J Clin Nutr 2004;79(6):969-73
25. Granato D, Blum S, Rossle C, et al. Effects of parenteral lipid emulsions with different fatty acid composition on immune cell functions in vitro. J Parenter Enteral Nutr 2000;24(2):113-18
26. Yaqoob P, Knapper JA, Webb DH, et al. Effect of olive oil on immune function in middle-aged men. Am J Clin Nutr 1998;67(1):129-35
27. Cury-Boaventura MF, Gorjão R, De Lima TM, et al. Comparative toxicity of oleic and linoleic acid on human lymphocytes. Life Sci 2006;78(13):1448-56
28. Schmitz G, Ecker J. The opposing effects of n-3 and n-6 fatty acids. Prog Lipid Res 2008;47(2):147-55
29. Poudyal H, Panchal SK, Diwan V, Brown L. Omega-3 fatty acids and metabolic syndrome: effects and emerging mechanisms of action. Prog Lipid Res 2011;50(4):372-87
30. Im DS. Omega-3 fatty acids in anti-inflammation (pro-resolution) and GPCRs. Prog Lipid Res 2012;51(3):232-7
31. Russo GL. Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention. Biochem Pharmacol 2009;77(6):937-46
32. Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother 2002;56(8):365-79
33. Xu Z, Li Y, Wang J, et al. Effect of omega-3 polyunsaturated fatty acids to reverse biopsy-proven parenteral nutrition-associated liver disease in adults. Clin Nutr 2012;31(2):217-23
34. Lilja HE, Finkel Y, Paulsson M, Lucas S. Prevention and reversal of intestinal failure-associated liver disease in premature infants with short bowel syndrome using intravenous fish oil in combination with omega-6/9 lipid emulsions. J Pediatr Surg 2011;46(7):1361-7
35. Diamond IR, Sterescu A, Pencharz PB, Wales PW. The rationale for the use of parenteral omega-3 lipids in children with short bowel syndrome and liver disease. Pediatr Surg Int 2008;24(7):773-8
36. Diamond IR, Sterescu A, Pencharz PB, et al. Changing the paradigm: omegaven for the treatment of liver failure in pediatric short bowel syndrome. J Pediatr Gastroenterol Nutr 2009;48(2):209-15
37. Fürst P, Kuhn K. Fish oil emulsions: what benefits can they bring? Clin Nutr 2000;19(1):7-14
38. Biolo G, Grimble G, Preiser JC, et al. Position paper of the ESICM Working Group on nutrition and metabolism. Intensive Care Med 2002;28(11):1512-20
39. Grimm H, Tibell A, Norrlind B, et al. Immunoregulation by parenteral lipids: impact of the n-3 to n-6 fatty acid ratio. J Parenter Enteral Nutr 1994;18(5):417-21
40. Grimm H, Schott J, Schwemmle K. Development of an immuno-neutral lipid emulsion for optimal postoperative management of intensive care patients. Langenbecks Arch Chir Suppl Kongressbd 1998;115:599-604
41. Davis BC, Kris-Etherton PM. Achieving optimal essential fatty acid status in vegetarians: current knowledge and practical implications. Am J Clin Nutr 2003;78(3):640S-6S
42. Slim R, Hammock BD, Toborek M, et al. The role of methyl-linoleic acid epoxide and diol metabolites in the amplified toxicity of linoleic acid and polychlorinated biphenyls to vascular endothelial cells. Toxicol Appl Pharmacol 2001;171(3):184-93
43. Sammon AM. Dietary linoleic acid, immune inhibition and disease. Postgrad Med J 1999;75(881):129-32
44. James MJ, Gibson RA, Cleland LG. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr 2000;71(1):343S-8S
45. Buenestado A, Cortijo J, Sanz MJ, et al. Olive oil-based lipid Emulsion's neutral effects on neutrophil functions and leukocyte-endothelial cell interactions. J Parenter Enteral Nutr 2006;30(4):286-96
46. Fraser I, Neoptolemos J, Woods P, et al. The effect of intralipid on human lymphocyte and monocyte function. Clin Nutr 1983;2(1):37-40
47. Grimm H, Tibell A, Norrlind B, et al. Nutrition and allorejection impact of lipids. Transpl Immunol 1995;3(1):62-7
48. Cavicchi M, Beau P, Crenn P, et al. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med 2000;132(7):525-32
49. Stanley JC. Should we be concerned about the dietary w-6:w-3 polyunsaturated fatty acid ratio? Lipid Technol 2007;19(5):112-13
50. Grau-Carmona T, Morán-Garća V, Garća-de-Lorenzo A, et al. Effect of an enteral diet enriched with eicosapentaenoic acid, gamma-linolenic acid and anti-oxidants on the outcome of mechanically ventilated, critically ill, septic patients. Clin Nutr 2011;30(5):578-84
51. Fan YY, Chapkin RS. Importance of dietary gamma-linolenic acid in human health and nutrition. J Nutr 1998;128(9):1411-14
52. DeLuca P, Rothman D, Zurier RB. Marine and botanical lipids as immunomodulatory and therapeutic agents in the treatment of rheumatoid arthritis. Rheum Dis Clin North Am 1995;21(3):759-77
53. Fan YY, Ramos KS, Chapkin RS. Dietary gamma-linolenic acid enhances mouse macrophage-derived prostaglandin E1 which inhibits vascular smooth muscle cell proliferation. J Nutr 1997;127(9):1765-71
54. Pacht ER, DeMichele SJ, Nelson JL, et al. Enteral nutrition with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Crit Care Med 2003;31(2):491-500
55. Pontes-Arruda A, Aragão AMA, Albuquerque JD. Effects of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Crit Care Med 2006;34(9):2325-33
56. Singer P, Theilla M, Fisher H, et al. Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury. Crit Care Med 2006;34(4):1033-8
57. Bernabe-Garcia M, Lopez-Alarcon M, Blanco-Favela F, et al. Beneficial effects of the n-3 long-chain polyunsaturated fatty acids in surgical patients: updating the evidence. Prostaglandins Leukot Essent Fatty Acids 2011;85(5):261-6
58. Burdge G. Metabolism of alpha-linolenic acid in humans. Prostaglandins Leukot Essent Fatty Acids 2006;75(3):161-8
59. Burdge GC, Calder PC. Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reprod Nutr Dev 2005;45(5):581-98
60. Brenna JT, Salem N Jr, Sinclair AJ, Cunnane SC. alpha-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot Essent Fatty Acids 2009;80(2-3):85
61. Barceló-Coblijn G, Collison LW, Jolly CA, Murphy EJ. Dietary alpha-linolenic acid increases brain but not heart and liver docosahexaenoic acid levels. Lipids 2005;40(8):787-98
62. Barceló-Coblijn G, Murphy EJ. Alpha-linolenic acid and its conversion to longer chain n-3 fatty acids: benefits for human health and a role in maintaining tissue n-3 fatty acid levels. Prog Lipid Res 2009;48(6):355-74
63. Burdge G, Wootton S. Conversion of alpha-linolenic acid to palmitic, palmitoleic, stearic and oleic acids in men and women. Prostaglandins Leukot Essent Fatty Acids 2003;69(4):283-90
64. Vijaimohan K, Jainu M, Sabitha K, et al. Beneficial effects of alpha linolenic acid rich flaxseed oil on growth performance and hepatic cholesterol metabolism in high fat diet fed rats. Life Sci 2006;79(5):448-54
65. Morise A, Sérougne C, Gripois D, et al. Effects of dietary alpha linolenic acid on cholesterol metabolism in male and female hamsters of the LPN strain. J Nutr Biochem 2004;15(1):51-61
66. Morise A, Mourot J, Riottot M, et al. Dose effect of alpha-linolenic acid on lipid metabolism in the hamster. Reprod Nutr Dev 2005;45(4):405-18
67. Cunnane SC, Hamadeh MJ, Liede AC, et al. Nutritional attributes of traditional flaxseed in healthy young adults. Am J Clin Nutr 1995;61(1):62-8
68. Mandaşescu S, Mocanu V, Dascali̧t a A, et al. Flaxseed supplementation in hyperlipidemic patients. Rev Med Chir Soc Med Nat Iasi 2005;109(3):502-6
69. Caughey GE, Mantzioris E, Gibson RA, et al. The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 1996;63(1):116-22
70. Thies F, Miles E, Nebe-von-Caron G, et al. Influence of dietary supplementation with long-chain n-3 or n-6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults. Lipids 2001;36(11):1183-93
71. Zhao G, Etherton TD, Martin KR, et al. Dietary alpha-linolenic acid reduces inflammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women. J Nutr 2004;134(11):2991-7
72. Riediger ND, Othman RA, Suh M, Moghadasian MH. A systemic review of the roles of n-3 fatty acids in health and disease. J Am Diet Assoc 2009;109(4):668-79
73. Tai CC, Ding ST. N-3 polyunsaturated fatty acids regulate lipid metabolism through several inflammation mediators: mechanisms and implications for obesity prevention. J Nutr Biochem 2010;21(5):357-63
74. Innis S, Novak E, Keller B. Long chain omega-3 fatty acids: micronutrients in disguise. Prostaglandins Leukot Essent Fatty Acids 2013;88(1):91-5
75. Lombardo YB, Chicco AG. Effects of dietary polyunsaturated n-3 fatty acids on dyslipidemia and insulin resistance in rodents and humans. A review. J Nutr Biochem 2006;17(1):1-13
76. Calder PC. Long-chain n-3 fatty acids and cardiovascular disease: further evidence and insights. Nutr Res 2004;24(10):761-72
77. Torrejon C, Jung U, Deckelbaum R. n-3 Fatty acids and cardiovascular disease: actions and molecular mechanisms. Prostaglandins Leukot Essent Fatty Acids 2007;77(5):319-26
78. Calder P, Grimble R. Polyunsaturated fatty acids, inflammation and immunity. Eur J Clin Nutr 2002;56:S14-19
79. Leaf A, Kang JX. Omega-3 fatty acids and cardiovascular disease. In: Simopoulos AP, Pavlou KN, editor. Nutrition and fitness: diet, genes, physical activity and health. Volume 89 World Rev Nutr Diet. Karger; Basel: 2001. p. 161-72
80. Adkins Y, Kelley DS. Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids. J Nutr Biochem 2010;21(9):781-92
81. James M, Proudman S, Cleland L. Fish oil and rheumatoid arthritis: past, present and future. Proc Nutr Soc 2010;69(03):316-23
82. Calder PC. Immunomodulation by omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 2007;77(5):327-35
83. Seidner DL, Mascioli EA, Istfan NW, et al. Effects of long-chain triglyceride emulsions on reticuloendothelial system function in humans. J Parenter Enteral Nutr 1989;13(6):614-19
84. Gura KM, Lee S, Valim C, et al. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics 2008;121(3):e678-e86
85. Kruimel JW, Naber TH, van der Vliet JA, et al. Parenteral structured triglyceride emulsion improves nitrogen balance and is cleared faster from the blood in moderately catabolic patients. J Parenter Enteral Nutr 2001;25(5):237-44
86. Lehner F, Demmelmair H, Roschinger W, et al. Metabolic effects of intravenous LCT or MCT/LCT lipid emulsions in preterm infants. J Lipid Res 2006;47(2):404-11
87. Goulet O, de Potter S, Antébi H, et al. Long-term efficacy and safety of a new olive oil-based intravenous fat emulsion in pediatric patients: a double-blind randomized study. Am J Clin Nutr 1999;70(3):338-45
88. Upadhyay N, Kumar R, Mandotra S, et al. Safety and healing efficacy of Sea buckthorn (Hippophae rhamnoides L.) seed oil on burn wounds in rats. Food Chem Toxicol 2009;47(6):1146-53
89. Yang B, Kallio H. Composition and physiological effects of sea buckthorn (Hippophaë) lipids. Trends Food Sci Tech 2002;13(5):160-7
90. Xing J, Yang B, Dong Y, et al. Effects of sea buckthorn (Hippophaë rhamnoides L.) seed and pulp oils on experimental models of gastric ulcer in rats. Fitoterapia 2002;73(7):644-50
91. Asif M. Health effects of omega-3, 6, 9 fatty acids: perilla frutescens is a good example of plant oils. Orient Pharm Exp Med 2011;11(1):51-9
92. Kurowska E, Dresser G, Deutsch L, et al. Bioavailability of omega-3 essential fatty acids from perilla seed oil. Prostaglandins Leukot Essent Fatty Acids 2003;68(3):207-12
93. Chang HH, Chen CS, Lin JY. Dietary perilla oil lowers serum lipids and ovalbumin-specific IgG1, but increases total IgE levels in ovalbumin-challenged mice. Food Chem Toxicol 2009;47(4):848-54
94. Ihara-Watanabe M, Umekawa H, Takahashi T, Furuichi Y. Comparative effects of safflower oil and perilla oil on serum and hepatic lipid levels, fatty acid compositions of serum and hepatic phospholipids, and hepatic mRNA expressions of 3-hydroxy-3-methylglutaryl CoA reductase, LDL receptor, and cholesterol 7alpha-hydroxylase in young and adult rats. Food Res Int 2000;33(10):893-900
95. Cho YY, Kwon EY, Kim HJ, et al. Low trans structured fat from flaxseed oil improves plasma and hepatic lipid metabolism in apo E-/-mice. Food Chem Toxicol 2009;47(7):1550-5
96. Espada C, Berra M, Martinez M, et al. Effect of Chia oil (Salvia hispanica) rich in w-3 fatty acids on the eicosanoid release, apoptosis and T-lymphocyte tumor infiltration in a murine mammary gland adenocarcinoma. Prostaglandins Leukot Essent Fatty Acids 2007;77(1):21-8
97. Garnacho-Montero J, Ortiz-Leyba C, Jiménez-Jiménez F, et al. Clinical and metabolic effects of two lipid emulsions on the parenteral nutrition of septic patients. Nutrition 2002;18(2):134-8
98. Chen FM, Wang JY, Huang TJ, et al. Efficacy of medium-chain triglycerides compared with long-chain triglycerides in total parenteral nutrition in patients with digestive tract cancer undergoing surgery. Kaohsiung J Med Sci 2005;21(11):487-94
99. Grau T, Ruiz de Adana JC, Zubillaga S, et al. Randomized study of two different fat emulsions in total parenteral nutrition of malnourished surgical patients: effect of infectious morbidity and mortality. Nutr Hosp 2003;18(3):159
100. Radermacher P, Santak B, Strobach H, et al. Fat emulsions containing medium chain triglycerides in patients with sepsis syndrome: effects on pulmonary hemodynamics and gas exchange. Intensive Care Med 1992;18(4):231-4
101. Smirniotis V, Kostopanagiotou G, Vassiliou J, et al. Long chain versus medium chain lipids in patients with ARDS: effects on pulmonary haemodynamics and gas exchange. Intensive Care Med 1998;24(10):1029-33
102. Smyrniotis V, Kostopanagiotou G, Arkadopoulos N, et al. Long-chain versus medium-chain lipids in acute pancreatitis complicated by acute respiratory distress syndrome: effects on pulmonary hemodynamics and gas exchange. Clin Nutr 2001;20(2):139-43
103. Chambrier C, Lauverjat M, Bouletreau P. Structured triglyceride emulsions in parenteral nutrition. Nutr Clin Pract 2006;21(4):342-50
104. Sandstrom R, Hyltander A, Korner U, Lundholm K. Structured triglycerides were well tolerated and induced increased whole body fat oxidation compared with long-chain triglycerides in postoperative patients. J Parenter Enteral Nutr 1995;19(5):381-6
105. Gobel Y, Koletzko B, Bohles HJ, et al. Parenteral fat emulsions based on olive and soybean oils: a randomized clinical trial in preterm infants. J Pediatr Gastroenterol Nutr 2003;37(2):161-7
106. Hartman C, Ben-Artzi E, Berkowitz D, et al. Olive oil-based intravenous lipid emulsion in pediatric patients undergoing bone marrow transplantation: a short-term prospective controlled trial. Clin Nutr 2009;28(6):631-5
107. Reimund JM, Rahmi G, Escalin G, et al. Efficacy and safety of an olive oil-based intravenous fat emulsion in adult patients on home parenteral nutrition. Aliment Pharmacol Ther 2005;21(4):445-54
108. Garnacho-Montero J, Ortiz-Leyba C, Garnacho-Montero M, et al. Effects of three intravenous lipid emulsions on the survival and mononuclear phagocyte function of septic rats. Nutrition 2002;18(9):751-4
109. Umpierrez GE, Spiegelman R, Zhao V, et al. A double-blind, randomized clinical trial comparing soybean oil-based versus olive oil-based lipid emulsions in adult medical-surgical intensive care unit patients requiring parenteral nutrition. Crit Care Med 2012;40(6):1792-8
110. Onar P, Yildiz BD, Yildiz EA, et al. Olive oil-based fat emulsion versus soy oil-based fat emulsion in abdominal oncologic surgery. Nutr Clin Pract 2011;26(1):61-5
111. Mateu-de Antonio J, Grau S, Luque S, et al. Comparative effects of olive oil-based and soyabean oil-based emulsions on infection rate and leucocyte count in critically ill patients receiving parenteral nutrition. Br J Nutr 2008;99(4):846-54
112. Tappy L, Berger MM, Schwarz JM, et al. Metabolic effects of parenteral nutrition enriched with n-3 polyunsaturated fatty acids in critically ill patients. Clin Nutr 2006;25(4):588-95
113. Khor BS, Liaw SJ, Shih HC, Wang LS. Randomized, double blind, placebo-controlled trial of fish-oil-based lipid emulsion infusion for treatment of critically ill patients with severe sepsis. Asian J Surg 2011;34(1):1-10
114. Liang B, Wang S, Ye YJ, et al. Impact of postoperative omega-3 fatty acid-supplemented parenteral nutrition on clinical outcomes and immunomodulations in colorectal cancer patients. World J Gastroenterol 2008;14(15):2434-9
115. Jiang Z, Wilmore D, Wang X, et al. Randomized clinical trial of intravenous soybean oil alone versus soybean oil plus fish oil emulsion after gastrointestinal cancer surgery. Br J Surg 2010;97(6):804-9
116. Heller AR, Rossler S, Litz RJ, et al. Omega-3 fatty acids improve the diagnosis-related clinical outcome. Crit Care Med 2006;34(4):972-9
117. Chen B, Zhou Y, Yang P, et al. Safety and efficacy of fish oil-enriched parenteral nutrition regimen on postoperative patients undergoing major abdominal surgery a meta-analysis of randomized controlled trials. J Parenter Enteral Nutr 2010;34(4):387-94
118. Wei C, Hua J, Bin C, Klassen K. Impact of lipid emulsion containing fish oil on outcomes of surgical patients: systematic review of randomized controlled trials from Europe and Asia. Nutrition 2010;26(5):474-81
119. de Miranda Torrinhas RS, Santana R, Garcia T, et al. Parenteral fish oil as a pharmacological agent to modulate postoperative immune response: a randomized, double-blind, and controlled clinical trial in patients with gastrointestinal cancer. Clin Nutr 2013;32(4):503-10
120. Xiong J, Zhu S, Zhou Y, et al. Regulation of omega-3 fish oil emulsion on the SIRS during the initial stage of severe acute pancreatitis. J Huazhong Univ Sci Technolog Med Sci 2009;29(1):35-8
121. Wang X, Li W, Li N, Li J. w-3 fatty acids-supplemented parenteral nutrition decreases hyperinflammatory response and attenuates systemic disease sequelae in severe acute pancreatitis: a randomized and controlled study. J Parenter Enteral Nutr 2008;32(3):236-41
122. Wichmann MW, Thul P, Czarnetzki HD, et al. Evaluation of clinical safety and beneficial effects of a fish oil containing lipid emulsion (Lipoplus, MLF541): data from a prospective, randomized, multicenter trial. Crit Care Med 2007;35(3):700-6
123. Barbosa VM, Miles EA, Calhau C, et al. Effects of a fish oil containing lipid emulsion on plasma phospholipid fatty acids, inflammatory markers, and clinical outcomes in septic patients: a randomized, controlled clinical trial. Crit Care 2010;14(1):R5
124. Grimm H, Mertes N, Goeters C, et al. Improved fatty acid and leukotriene pattern with a novel lipid emulsion in surgical patients. Eur J Nutr 2006;45(1):55-60
125. Grimm H. A balanced lipid emulsion-a new concept in parenteral nutrition. Clin Nutr Suppl 2005;1(3):25-30
126. Senkal M, Geier B, Hannemann M, et al. Supplementation of w-3 fatty acids in parenteral nutrition beneficially alters phospholipid fatty acid pattern. J Parenter Enteral Nutr 2007;31(1):12-17
127. Mayer K, Fegbeutel C, Hattar K, et al. w-3 vs. w-6 lipid emulsions exert differential influence on neutrophils in septic shock patients: impact on plasma fatty acids and lipid mediator generation. Intensive Care Med 2003;29(9):1472-81
128. Pluess TT, Hayoz D, Berger MM, et al. Intravenous fish oil blunts the physiological response to endotoxin in healthy subjects. Intensive Care Med 2007;33(5):789-97
129. Mayer K, Gokorsch S, Fegbeutel C, et al. Parenteral nutrition with fish oil modulates cytokine response in patients with sepsis. Am J Respir Crit Care Med 2003;167(10):1321-8
130. Han YY, Lai SL, Ko WJ, et al. Effects of fish oil on inflammatory modulation in surgical intensive care unit patients. Nutr Clin Pract 2012;27(1):91-8
131. Wang J, Yu JC, Kang WM, Ma ZQ. Superiority of a fish oil-enriched emulsion to medium-chain triacylglycerols/long-chain triacylglycerols in gastrointestinal surgery patients: a randomized clinical trial. Nutrition 2012;28(6):623-9
132. Mirtallo JM, Dasta JF, Kleinschmidt KC, Varon J. State of the art review: intravenous fat emulsions: current applications, safety profile, and clinical implications. Ann Pharmacother 2010;44(4):688-700
133. Koletzko B. Intravenous lipid emulsions for infants: when and which? Am J Clin Nutr 2012;96(2):225-6
134. Demirel G, Oguz SS, Celik IH, et al. The metabolic effects of two different lipid emulsions used in parenterally fed premature infants-A randomized comparative study. Early Hum Dev 2012;88(7):499-501
135. Gawecka A, Michalkiewicz J, Kornacka MK, et al. Immunologic properties differ in preterm infants fed olive oil vs soy-based lipid emulsions during parenteral nutrition. J Parenter Enteral Nutr 2008;32(4):448-53
136. Carlson SJ, Fallon EM, Kalish BT, et al. The role of the w-3 fatty acid DHA in the human life cycle. J Parenter Enteral Nutr 2013;37(1):15-22
137. D'Ascenzo R, D'Egidio S, Angelini L, et al. Parenteral nutrition of preterm infants with a lipid emulsion containing 10% fish oil: effect on plasma lipids and long-chain polyunsaturated fatty acids. J Pediatr 2011;159(1):33-8; e1
138. Tomsits E, Pataki M, Tolgyesi A, et al. Safety and efficacy of a lipid emulsion containing a mixture of soybean oil, medium-chain triglycerides, olive oil, and fish oil: a randomised, double-blind clinical trial in premature infants requiring parenteral nutrition. J Pediatr Gastroenterol Nutr 2010;51(4):514-21
139. Goulet O, Antébi H, Wolf C, et al. A new intravenous fat emulsion containing soybean oil, medium-chain triglycerides, olive oil, and fish oil: a single-center, double-blind randomized study on efficacy and safety in pediatric patients receiving home parenteral nutrition. J Parenter Enteral Nutr 2010;34(5):485-95
140. Gura KM, Duggan CP, Collier SB, et al. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics 2006;118(1):e197-201
141. Puder M, Valim C, Meisel JA, et al. Parenteral fish oil improves outcomes in patients with parenteral nutrition associated liver injury. Ann Surg 2009;250(3):395-402
142. Lee SI, Valim C, Johnston P, et al. Impact of fish oil-based lipid emulsion on serum triglyceride, bilirubin, and albumin levels in children with parenteral nutrition-associated liver disease. Pediatr Res 2009;66(6):698-703
143. Sigalet D, Boctor D, Robertson M, et al. Improved outcomes in paediatric intestinal failure with aggressive prevention of liver disease. Eur J Pediatr Surg 2009;19(06):348-53
144. Pironi L, Colecchia A, Guidetti M, et al. Fish oil-based emulsion for the treatment of parenteral nutrition associated liver disease in an adult patient. E Spen Eur E J Clin Nutr Metab 2010;5(5):e243-e46
145. Fuchs J, Fallon EM, Gura KM, Puder M. Use of an omega-3 fatty acid-based emulsion in the treatment of parenteral nutrition-induced cholestasis in patients with microvillous inclusion disease. J Pediatr Surg 2011;46(12):2376-82
146. Heller AR, Rossel T, Gottschlich B, et al. Omega-3 fatty acids improve liver and pancreas function in postoperative cancer patients. Int J Cancer 2004;111(4):611-16
147. Shin JI, Namgung R, Park MS, Lee C. Could lipid infusion be a risk for parenteral nutrition-associated cholestasis in low birth weight neonates? Eur J Pediatr 2008;167(2):197-202
148. Zambrano E, El-Hennawy M, Ehrenkranz RA, et al. Total parenteral nutrition induced liver pathology: an autopsy series of 24 newborn cases. Pediatr Dev Pathol 2004;7(5):425-32
149. Colomb V, Jobert-Giraud A, Lacaille F, et al. Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children. J Parenter Enteral Nutr 2000;24(6):345-50
150. Reimund JM, Arondel Y, Joly F, et al. Potential usefulness of olive oil-based lipid emulsions in selected situations of home parenteral nutrition-associated liver disease. Clin Nutr 2004;23(6):1418-25
151. Thomas-Gibson S, Jawhari A, Atlan P, et al. Safe and efficacious prolonged use of an olive oil-based lipid emulsion (ClinOleic-) in chronic intestinal failure. Clin Nutr 2004;23(4):697-703
152. Pálová S, Charvat J, Kvapil M. Comparison of soybean oil-and olive oil-based lipid emulsions on hepatobiliary function and serum triacylglycerols level during realimentation. J Int Med Res 2008;36(3):587-93
153. Staun M, Pironi L, Bozzetti F, et al. ESPEN guidelines on parenteral nutrition: home parenteral nutrition (HPN) in adult patients. Clin Nutr 2009;28(4):467-79
154. Klek S, Chambrier C, Singer P, et al. Four-week parenteral nutrition using a third generation lipid emulsion (SMOFlipid)-A double-blind, randomised, multicentre study in adults. Clin Nutr 2013;32(2):224-31
155. Vanek VW, Seidner DL, Allen P, et al. A.S.P.E.N. position paper: clinical role for alternative intravenous fat emulsions. Nutr Clin Pract 2012;27(2):150-92